大理大学学报 ›› 2022, Vol. 7 ›› Issue (10): 15-21.

• 药学 • 上一篇    下一篇

应用DURDUE评价大理市某医院青年缺血性脑卒中患者用药情况

伍蓉霜,马安翠,沈 磊*   

  1. 1.大理大学药学院,云南大理 6710002.大理大学第一附属医院药剂科,云南大理 671000

  • 收稿日期:2022-04-22 修回日期:2022-08-11 出版日期:2022-10-15 发布日期:2022-11-15
  • 通讯作者: 沈磊,副教授,博士,E-mail:shenlei@dali.edu.cn。
  • 作者简介:伍蓉霜,硕士研究生,主要从事临床药学研究。
  • 基金资助:

    云南省基础研究计划项目(202101AT070030

Evaluation of the Drug Utilization of Young Patients with Cerebral Ischemic Stroke in a Hospital in Dali City by DUR and DUE

Wu RongshuangMa AncuiShen Lei* #br#   

  1. 1.College of PharmacyDali UniversityDaliYunnan 671000China2. Department of PharmacyThe First Affiliated Hospital of Dali UniversityDaliYunnan 671000China

  • Received:2022-04-22 Revised:2022-08-11 Online:2022-10-15 Published:2022-11-15

摘要:

[摘要] 目的:评价大理大学第一附属医院20182020年青年缺血性脑卒中患者用药情况及用药合理性。方法:采用药物利用评价(DUR)和药物利用评估(DUE)评价患者使用药物种类、频次及合理性。结果:75例患者使用药物共1361种,含西药48种和中药注射剂13种,其中调血脂药使用比例最高,达98.7%DUR结果显示有11种药物的药物利用指数(DUI>124种药物的DUI=126种药物的DUI<1DUI>1的西药主要是抑酸药和降压药,DUI<1的药物种类广,多为联合用药减量所致。DUE结果显示,与药物相关的实验室检查指标监测率偏低,患者不良反应主要为胃肠道反应。经药物治疗后,74例患者临床症状有所改善。结论:该院青年缺血性脑卒中患者药物种类选择合理,但须加强抑酸药和降压药使用管理,同时加强治疗过程中对相关实验室检查指标及不良反应的监测。

关键词:

"> font-size:10.5pt, ">缺血性脑卒中, 青年, 药物利用评估, 药物利用评价, 不良反应

Abstract:

AbstractObjectiveTo evaluate the drug utilization and rationality of young patients with cerebral ischemic stroke in the First Affiliated Hospital of Dali University from 2018 to 2020. MethodsDrug utilization reviewDURand drug utilization evaluationDUEwere used to evaluate the typefrequency and rationality of drugs used by patients. Results61 drugs in 13 categories were applied in the treatment of 75 patientsincluding 48 western drugs and 13 traditional Chinese medicine injectionsamong which the proportion of lipid-regulating drugs was the highestreaching 98.7%. DUR results showed that the drug utilization indexDUIof 11 drugs was greater than 1the DUI of 24 drugs was 1and the DUI of 26 drugs was less than 1. Western drugs with DUI greater than 1 were mainly acid inhibitor and antihypertensive drugswhile drugs with DUI less than 1 were of a wide varietymostly caused by dose reduction in combination drugs. DUE results showed that the monitoring rate of drug-related laboratory test indicators was lowand the main adverse reactions were gastrointestinal reactions. After drug treatmentthe clinical symptoms of 74 patients were improved. ConclusionThe selection of drugs for young patients with cerebral ischemic stroke in this hospital is reasonablebut it is necessary to strengthen the management of acid inhibitor and antihypertensive drugsand strengthen the monitoring of related laboratory indicators and adverse reactions during treatment.

Key words:

"> font-size:10.5pt, ">cerebral ischemic stroke, youth, drug utilization review, drug utilization evaluation, adverse reactions

中图分类号: